Balyasny Asset Management’s Amedisys AMED Stock Holding History

Balyasny Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-320,000	Closed	-$31.5M	–	2877
2025 Q2	$31.5M	Hold	320,000	–	–	0.05%	496
2025 Q1	$29.6M	Sell	320,000 -278,600	-47%	-$25.7M	0.05%	456
2024 Q4	$54.3M	Buy	+598,600	New	+$55M	0.08%	302
2023 Q4	–	Sell	-450,000	Closed	-$42M	–	2464
2023 Q3	$42M	Buy	450,000 +375,500	+504%	+$34.7M	0.09%	317
2023 Q2	$6.81M	Buy	+74,500	New	+$6.11M	0.02%	947
2018 Q4	–	Sell	-30,000	Closed	-$3.54M	–	1366
2018 Q3	$3.54M	Buy	+30,000	New	+$3.31M	0.02%	821

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's AMED Position: Q3 2025 in Review

Balyasny Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 641,299 shares — an estimated $63.1M sold.

Balyasny Asset Management first reported a position in AMED in Q2 2017 and held it in 17 quarters. The position peaked at $63.1M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Balyasny Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Balyasny Asset Management sold 641,299 Amedisys shares in Q3 2025, an estimated $63.1M.
Balyasny Asset Management first reported a position in Amedisys in Q2 2017 and held it in 17 quarters.
Balyasny Asset Management's Amedisys position peaked at $63.1M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.